Laval University: Insulin Resistance trials

The registry lists 13 Insulin Resistance studies with Laval University as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 2Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Cranberry on Gut and Metabolic HealthRecruitingNCT07460856Not applicable
• Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot StudyCompletedNCT01849068Phase 3Results posted
• Effects of a 12-week Supervised Exercise Program Post Bariatric Surgery on Body Composition, Muscle Strength, and Insulin ResistanceCompletedNCT07651254Not applicable
• Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in HumansCompletedNCT04130321Not applicable
• Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic SyndromeCompletedNCT04117802Not applicable
• Effect of Cranberry and Agaves Extract on Microbiota and Intestinal HealthCompletedNCT03800277Not applicable
• Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic SyndromeCompletedNCT03754504Not applicable
• Brown Seaweed Extract on Glycemic Control and Body WeightCompletedNCT03075943Not applicable
• Pilot Study on Metabolic Effects of Fish Peptides and Vitamin DCompletedNCT02668159Not applicable
• Beneficial Effects of a Polyphenol Enriched Beverage on Type 2 Diabetes Prevention and on Cardiovascular Risk Profile of Men and Women With Insulin Resistance.CompletedNCT01766570Not applicable
• Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.CompletedNCT01766557Not applicable
• Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin ResistanceCompletedNCT01215903Phase 2
• Dietary Fish Protein in Subjects With Insulin ResistanceCompletedNCT00400036Phase 2